|
|
|
|
|
As a speaker, you are able to:
- Enhance your personal and public standing as a recognised leader in the industry
- Lead and shape your market
- Capitalise on meeting all the best people
- Discover prime research partnership opportunities all under one roof
- Obtain excellent returns saving your time and energy travelling around the region
| |
Target your market!
Contact us for further details
|
|
|
|
|
|
Call for media partners
Capitalise on this ideal platform to market your publication and form strategic relationships through networking at the World Drug Targets Congress 2009!
- Brand your publication with an event that the industry believes in
- Fully capitalise on our integrated marketing campaign
- Increase your customer contact and business opportunities
- Gain a wider exposure to International organisations
- Give clients “hands on” experience with your products / services
- Gain exclusive interviews with the region’s movers and shakers
- Avail yourself of invaluable editorial & feature content at the conference
For more information on how your publication can profile as the industry leader, please contact Marcia Ardila on +44 (0) 207 539 4335 or email marcia.ardila@terrapinn.com.
 In January of 2009 mAbs, the first international peer-reviewed journal of its kind to focus exclusively on monoclonal antibodies, will be launched. We believe that this is an excellent time to start the journal because of the increasing focus on mAbs as therapeutics.
mAbs will be a multi-disciplinary journal dedicated to the art and science of mAb research and development. mAbs will publish three general types of papers, (i) Original research, (ii) Reviews,
(iii) Commentaries and perspectives. Original papers will cover topics important in the mAb field. Reviews will take several forms and will generally be invited. Commentaries and perspectives on
any aspect of mAb R&D will be welcome. Visit our website: www.landesbioscience.com/journals/mabs
 PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modeling, product/technology forecasts and market trends evaluation. Visit our website: www.pharmavision.co.uk
Published by Espicom Business Intelligence, Pharma Agreement News is the twice-monthly business publication that concisely reports on hundreds of agreements and deals between phamaceutical companies worldwide.
|
|
|
|
|
|
|
|
|
|
